Johnson & Johnson CEO: Our aim is to become the number one oncology company

CNBC’s Angelica Peebles and Johnson & Johnson CEO Joaquin Duato join 'Squawk on the Street' to discuss the company's goals in oncology, the future of cancer treatments, state of the talc lawsuits, drug price negotiations, and more.

Jun 3, 2024 - 21:00

0 4

Johnson & Johnson CEO: Our aim is to become the number one oncology company

CNBC’s Angelica Peebles and Johnson & Johnson CEO Joaquin Duato join 'Squawk on the Street' to discuss the company's goals in oncology, the future of cancer treatments, state of the talc lawsuits, drug price negotiations, and more.

Tags:

Previous Article

Harvard fellow: CFPB's 'buy now, pay later' regulation isn't enough — nothing 's...

Shipping strain should start to regulate in medium-term, says Flexport CEO Ryan ...

admin

admin

This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.